Fragmented variables
- Heterogeneous names, units and intervals
- Domain-specific isolated endpoints
- Manual integration that is difficult to reproduce
- ML fed directly with raw variables
Deterministic infrastructure for turning blood, fecal microbiota, metabolomics, genetics, phenotypes, interventions and time into reproducible participant and cohort representations. Within-domain patterns and cross-patterns can be frozen before statistics or machine learning are applied.
Multimodal studies accumulate source families with different scales, frequencies and meanings. AXIS preserves provenance and creates a prior structure layer for within-domain patterns and cross-patterns without turning research into a black box.
AXIS converts heterogeneous study data into a version-consistent state matrix. The protocol, variables and inference rules are fixed before execution, so every result can be reproduced and traced back to its original measurement.
The question, population, domains, interventions, visits and permitted outputs are mapped before the first execution.
Accepted inputs are normalized and processed only through the parameters and rules defined for that study.
Each participant and visit becomes a structured state vector before alignment at cohort level.
The matrix is conceptual and does not represent scientific results. It shows how a study can compare structured dimensions without losing participant-level evidence paths.
AXIS provides deterministic features and evidence paths. Statistical conclusions remain a subsequent methodological layer.
Structured dimensions with confidence, coverage and provenance.
Version-consistent representations for comparison and validation.
Describe groups through activated patterns, not only mathematical distance.
Retain what changed, with what confidence and which evidence supported the transition.
Estimate how often defined relationships occur in a cohort.
Stable, interpretable features for downstream modeling.
Research configurations do not automatically inherit clinical validity, utility or commercial claims. Lifecycle state, configuration version and evidence status must remain explicit.
The strongest collaborations begin with the hypothesis, data contract, cohort definition and validation plan—not with an unrestricted parameter upload.